| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6181802 | Fertility and Sterility | 2015 | 6 Pages |
Abstract
Patient prognosis and embryo cohort quality seem to be major factors in MZT rate in women undergoing blastocyst transfer. Although technology-based effects cannot be excluded, patient and embryo characteristics play an important role.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jason M. M.D., Yelena M.D., Thomas A. M.D., Kathleen H. M.D., Eric J. M.D., Marie D. M.D., Kathleen M. B.S., Richard T. M.D.,